Healthcare service marketing must not make unsupported cure, success-rate, safety or FDA-status claims, and outcome claims need competent and reliable scientific evidence.
FTC Act Sections 5 and 12 (15 U.S.C. 45, 52)
What is FTC Deceptive Healthcare Marketing Practices (FTC Act Section 5)?
Healthcare service marketing must not make unsupported cure, success-rate, safety or FDA-status claims, and outcome claims need competent and reliable scientific evidence. Apply to US marketing for clinics, practices, telehealth, med spas, fertility, treatment and weight-loss programs that makes outcome, safety or FDA-status claims.
Healthcare service marketing must not make unsupported cure, success-rate, safety or FDA-status claims, and outcome claims need competent and reliable scientific evidence.
How can marketing teams comply?
Apply to US marketing for clinics, practices, telehealth, med spas, fertility, treatment and weight-loss programs that makes outcome, safety or FDA-status claims.
What is FTC Deceptive Healthcare Marketing Practices (FTC Act Section 5)?
Healthcare service marketing must not make unsupported cure, success-rate, safety or FDA-status claims, and outcome claims need competent and reliable scientific evidence.
The FTC requires food and beverage health and nutrition advertising claims to be truthful, not misleading and backed by competent and reliable scientific evidence, applying FDA labeling definitions as a benchmark.
Health, safety and efficacy claims for supplements, OTC drugs, health devices and wellness products must be backed by competent and reliable scientific evidence, generally human clinical trials of the product, and non-drug products must not claim to treat or cure disease.
Ads for OTC homeopathic drugs that make efficacy claims must convey that there is no scientific evidence the product works and that the claims rest only on 1700s homeopathic theories most modern experts reject.
Sexual wellness advertising must be truthful and substantiated: non-drug products may not claim to treat sexual disorders or match prescription drugs, and enlargement, performance and safety claims must not be deceptive.
Under FTC Act Section 5 and the VIZIO case, smart TV and streaming services must clearly disclose that they collect viewing data and share it, and get consent before collecting; privacy claims must not be misleading.
CARU's self-regulatory guidelines require ads directed at children under 13 to be clearly identified as ads, show products truthfully, avoid pressure tactics and unsafe depictions, and make purchase costs clear.
Request a free compliance scan of your homepage and book a time with Warrant.